Who owns AKARI THERAPEUTICS PLC SPONSORED?

Tip: Access positions for across all investors

Analyze quarterly positions in Akari Therapeutics Plc Sponsored with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Akari Therapeutics Plc Sponsored stock

Who bought or sold AKARI THERAPEUTICS PLC SPONSORED this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cresset Asset Management 823k $831k 4368% Sep 2025
 View chart
Palo Alto Investors 146k $148k 0% Sep 2025
 View chart
HighTower Advisors 79k $80k 0% Sep 2025
 View chart
CWA Asset Management 55k $16k 100% Dec 2025
 View chart
UBS Group 33k $9.5k 54658% Dec 2025
 View chart
HPM Partners 24k $24k 0% Sep 2025
 View chart
Virtu Financial 23k $22k 100% Sep 2025
 View chart
Two Sigma Securities 20k $20k 100% Sep 2025
 View chart
Independent Advisor Alliance 17k $4.9k 57% Dec 2025
 View chart
Accent Capital Management 10k $10k 0% Sep 2025
 View chart
Goss Wealth Management 6.8k $6.9k 0% Sep 2025
 View chart
Truvestments Capital 50.00 $51.000000 0% Sep 2025
 View chart
EverSource Wealth Advisors 44.00 $44.000000 -99% Sep 2025
 View chart
Cornerstone Planning Group 5.00 $1.000000 -29% Dec 2025
 View chart

Who sold out of Akari Therapeutics Plc Sponsored?

Fund or Company Name Date Sold Shares Held Valued At
Sabby Management Jun 2025 180k $210k
Omnia Family Wealth Sep 2025 28k $29k
Renaissance Technologies Jun 2025 17k $20k